Celecoxib ameliorates liver cirrhosis via reducing inflammation and oxidative stress along spleen-liver axis in rats-Reference-Cited by-同舟云学术

Celecoxib ameliorates liver cirrhosis via reducing inflammation and oxidative stress along spleen-liver axis in rats

Published:2021-05 Issue: Volume:272 Page:119203
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Tang Shihang,Huang Zhiyin,Jiang Jingsun,Gao Jinhang,Zhao Chong,Tai Yang,Ma Xiao,Zhang Linhao,Ye Yanting,Gan Can,Su Wei,Jia Xintong,Liu Rui,Wu Hao,Tang Chengwei

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference38 articles.

1. Liver cirrhosis;Tsochatzis;Lancet,2014

2. Hepatic fibrosis: concept to treatment;Trautwein;J. Hepatol.,2015

3. Thomas HT, Lindsey AE, Bernd S, Debbie LS. Targeting the gut-liver-immune axis to treat cirrhosis. Gut 15: gutjnl-2020-320786, 2020.

4. Protective role of spleen-derived macrophages in lung inflammation, injury and fibrosis induced by nitrogen mustard;Venosa;Am J Physiol Lung Cell Mol Physiol,2015

5. Monocyte subset accumulation in the human heart following acute myocardial infarction and the role of the spleen as monocyte reservoir;Van der Laan;Eur. Heart J.,2014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The independent prognostic value of Perioperative HVPG measurements in patients with portal hypertension and received Laparoscopic splenectomy plus esophagogastric devascularization;2024-07-12

2. Splenectomy ameliorates liver cirrhosis by restoring the gut microbiota balance;Cellular and Molecular Life Sciences;2024-01-12

3. The transcriptomic profile shows the protective effects of celecoxib on cirrhotic splenomegaly;Immunopharmacology and Immunotoxicology;2023-12-04

4. Disruption of cholangiocyte-B cell crosstalk by blocking the CXCL12-CXCR4 axis alleviates liver fibrosis;Cellular and Molecular Life Sciences;2023-11-27

5. Celecoxib abrogates concanavalin A-induced hepatitis in mice: Possible involvement of Nrf2/HO-1, JNK signaling pathways and COX-2 expression;International Immunopharmacology;2023-08